[go: up one dir, main page]

BR9909440A - Derivados de indol - Google Patents

Derivados de indol

Info

Publication number
BR9909440A
BR9909440A BR9909440-1A BR9909440A BR9909440A BR 9909440 A BR9909440 A BR 9909440A BR 9909440 A BR9909440 A BR 9909440A BR 9909440 A BR9909440 A BR 9909440A
Authority
BR
Brazil
Prior art keywords
group
aryl
lower alkyl
alkyl group
alkenyl
Prior art date
Application number
BR9909440-1A
Other languages
English (en)
Inventor
Yamasaki Noritsugu
Imoto Takafumi
Teruo Oku
Kayakiri Hiroshi
Onomura Osamu
Hiramura Takahiro
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9909440A publication Critical patent/BR9909440A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE INDOL"<D>. é fornecido um novo derivado de indol ou um sal do mesmo, que é representado pela fórmula: em que R~ 1~ representa um grupo aril alquila inferior, o referido grupo arila podendo ser substituído com um ou mais grupos selecionados do grupo que consiste em um átomo de halogênio, um grupo arila, um grupo heterocíclico, um grupo aril alquila inferior, um grupo aril alquenila inferior, um grupo halo - alquila inferior, um grupo cicloalquila inferior - alcóxi inferior, um grupo cicloalcóxi inferior - alquila inferior, um grupo aril alquinila inferior, um grupo arilóxi alquila inferior, um grupo aril alcóxi inferior, um grupo alquiltio inferior, um grupo alcóxi inferior, e um grupo alquenila; e R~ 2~ representa um grupo alquila inferior, um grupo alquenila inferior, um grupo arila, ou um grupo heterocíclico, cada um dos quais pode ser substituído com um átomo de hidrogênio, um grupo alquila inferior, um grupo alquenila inferior, ou um grupo arila. O composto da presente invenção possui atividade depressora de açúcar no sangue e atividade inibidora de PDE~ 5~, e é útil em medicina
BR9909440-1A 1998-04-06 1999-04-05 Derivados de indol BR9909440A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9362598 1998-04-06
PCT/JP1999/001798 WO1999051574A1 (en) 1998-04-06 1999-04-05 Indole derivatives

Publications (1)

Publication Number Publication Date
BR9909440A true BR9909440A (pt) 2000-12-26

Family

ID=14087520

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909440-1A BR9909440A (pt) 1998-04-06 1999-04-05 Derivados de indol

Country Status (7)

Country Link
US (1) US20050171185A1 (pt)
EP (1) EP1070705A4 (pt)
KR (1) KR20010052235A (pt)
CN (1) CN1150167C (pt)
BR (1) BR9909440A (pt)
CA (1) CA2327397A1 (pt)
WO (1) WO1999051574A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132087A4 (en) * 1998-11-13 2002-06-26 Fujisawa Pharmaceutical Co REMEDIES FOR POLYKYSTIC OVARY SYNDROME
CA2419033A1 (en) * 2000-08-11 2002-02-21 Earl Michael Gibbs Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
US6638965B2 (en) 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
AU2002226633A1 (en) * 2001-02-02 2002-08-12 Pfizer Limited Treatment of diabetes mellitus using vardenafil
TWI325317B (en) * 2001-09-05 2010-06-01 Eisai R&D Man Co Ltd Appetite-stimulating agents and remedies for anorexia
TW200533336A (en) * 2004-03-02 2005-10-16 Fujisawa Pharmaceutical Co Concomitant drugs
SMT202000540T1 (it) 2014-10-06 2020-11-10 Vertex Pharma Modulatori di regolatore di conduttanza transmembrana di fibrosi cistica
US10738030B2 (en) 2016-03-31 2020-08-11 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
JOP20190042B1 (ar) 2016-09-30 2021-08-17 Vertex Pharma مُعدِّل‏ لمنظم موصلية التليف الكيسي عبر الغشاء، وتركيبات صيدلانية، وطرق للعلاج، وعملية لتصنيع المُعدِّل
UY37513A (es) 2016-12-09 2018-07-31 Vertex Pharma Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador
US11253509B2 (en) 2017-06-08 2022-02-22 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
BR112020000941A2 (pt) 2017-07-17 2020-07-21 Vertex Pharmaceuticals Incorporated métodos de tratamento para fibrose cística
AU2018309043B2 (en) 2017-08-02 2022-03-31 Vertex Pharmaceuticals Incorporated Processes for preparing pyrrolidine compounds
CA3078893A1 (en) 2017-10-19 2019-04-25 Vertex Pharmaceuticals Incorporated Crystalline forms and compositions of cftr modulators
US11465985B2 (en) 2017-12-08 2022-10-11 Vertex Pharmaceuticals Incorporated Processes for making modulators of cystic fibrosis transmembrane conductance regulator
TWI810243B (zh) 2018-02-05 2023-08-01 美商維泰克斯製藥公司 用於治療囊腫纖化症之醫藥組合物
EP3774825A1 (en) 2018-04-13 2021-02-17 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US11681922B2 (en) * 2019-11-26 2023-06-20 Numenta, Inc. Performing inference and training using sparse neural network

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916774D0 (en) * 1989-07-21 1989-09-06 Bayer Ag New indole derivatives,a process for their preparation and their use in medicaments
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
DK0882718T3 (da) * 1995-12-28 2005-12-12 Astellas Pharma Inc Benzimidazolderivater
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
EP1000932B9 (en) * 1997-06-27 2005-12-28 Fujisawa Pharmaceutical Co., Ltd. Aromatic ring derivatives
BR9810456A (pt) * 1997-06-27 2001-09-25 Fujisawa Pharmaceutical Co Composto de sulfonamida, método para sua obtenção e seu uso farmacêutico
TW453999B (en) * 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives

Also Published As

Publication number Publication date
HK1037619A1 (en) 2002-02-15
US20050171185A1 (en) 2005-08-04
CN1303371A (zh) 2001-07-11
KR20010052235A (ko) 2001-06-25
WO1999051574A1 (en) 1999-10-14
EP1070705A1 (en) 2001-01-24
CN1150167C (zh) 2004-05-19
CA2327397A1 (en) 1999-10-14
EP1070705A4 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
BR9909440A (pt) Derivados de indol
BR9909146A (pt) Derivados de indol apresentando uma atividade antiviral
ES2063830T3 (es) Agentes antitumorales.
CY1110317T1 (el) Παραγωγα 3-υποκατεστημενης-4-πυριμιδονης
BRPI0418082A (pt) antagonista de receptor de adenosina a2a, agente para tratar e/ou prevenir doenças, composto, composição farmacêutica, e, método para tratar e/ou prevenir doenças associadas com receptor de adenosina a2a
NO20001045L (no) Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav
BR122017028096B8 (pt) composto, composição farmacêutica, e, uso do composto
BR0011274A (pt) Derivados tipo indol como inibidores de p38 quinase
GEP20032913B (en) Thienylazolylalcoxyethanamines, Their Preparation and Their Application as Medicaments
CO4910135A1 (es) Derivados cetolidos 6-0 sustituidos de la eritromicina que tienen actividad bacteriana
TR200100659T2 (tr) 5-HT2C agonistleri olarak piroloindoller, piridoindoller ve azepinoindoller.
BR9807132A (pt) Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
BR0214224A (pt) Derivado de 4,4-diflúor-1,2,3,4-tetrahidro-5h-1-benzazepina ou sal do mesmo
HUP0002353A2 (hu) IV típusú foszfodiészteráz inhibitor hatású 1-cikloalkil-1,8-naftiridin-4-on-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
BRPI0408591A (pt) derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda
DK0599890T3 (da) Geneserinderivater som cholinesteraseinhibitorer
BRPI0414738A (pt) derivados de ácido acético substituìdos
DE10199016I2 (de) Indol derivate zur Behandlung von Migraene
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
BR0011534A (pt) Alquilaminas aril substituìdas capazes de ativação de receptores colinérgicos nicotìnicos
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO4930268A1 (es) BENZO[e]ISOINDOLES Y BENZO[h]ISOQUINOLINAS TRICICLICOS
BR0315386A (pt) Abridor de canal de k ativado por cálcio de condutância grande
NO20012443D0 (no) Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO POR FUSAO DE: FUJISAWA PHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA INC. (JP)

Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1945 DE 15 - 04 - 2008.